ARTICLES BY ERIC LARSON
Medtech Material Selection For Performance And Feel
When designing a medical device, material selection can be difficult, especially with thousands of plastic material options available. While material properties, environmental effects, regulatory requirements, and cost almost always are considered, "feel" is often overlooked – despite its importance to user and patient satisfaction, as well as market success.
Continue Reading..
Medical Plastics: Material Selection Based On Feel
From prioritizing material properties to establishing desired values for each property, selecting plastic materials based on feel is a complicated undertaking. To elicit the most desirable user response from the device, it can be helpful to consider the what, rather than the how.
Continue Reading..
The People Who Turn An Idea Into A Deliverable Product
Drug developers and device engineers share more common ground than their distinct disciplines suggest, facing parallel pressures around design, safety, regulatory approval, and scalable performance.
Continue Reading..
09.15.26 -- Spanish Is Not One Regulatory Language
09/15/26 Med Device Online Newsletter
Continue Reading..
Who Exactly Owns Quality?
We’ve all heard the rhetorical question, “Who owns quality?” And we all reply with the answer they expect to hear: “We all do!” This mindset needs to be fully integrated into the minds and systems of a company.
Continue Reading..
8 Regulations Every Biotech & Pharma Quality Leader Must Know
Navigate essential biotech and pharma regulations safely. Learn how unifying global standards streamlines audits and accelerates development schedules.
Continue Reading..
The Life Sciences Guide To AI In Quality & Compliance
Implement AI in quality workflows without regulatory risk. Learn how strong governance and clear validation keep you audit-ready for compliance.
Continue Reading..
09.14.26 -- Precision Is Only The Beginning: Driving Better Device Outcomes
09/14/26 Med Device Online Newsletter
Continue Reading..
Chile's Easy Market Ends In 2028
For years, Chile has been a comparatively easy to enter market for the medtech industry. That era now has an expiration date. High-risk, technically complex products will be the most affected by a new decree.
Continue Reading..